Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02167243 · ClinicalTrials.gov registry record · NA
A Reinforcement Approach to Improve Diabetes Management
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT02167243 is a NA study that has completed, run by Yale University. The registered enrollment target is 62 participants.
The verdict
NCT02167243, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this project is to evaluate the efficacy of a behavioral economic intervention to improve self monitoring of blood glucose (SMBG) in adolescents and young adults with T1D. The intervention will reinforce patients for conducting SMBG, with escalating reinforcers provided when patients achieved sustained periods of testing at least 4 times/day at appropriate intervals. A 6-month trial will be conducted in which 60 patients will be randomized to: (1) standard care or (2) standard care plus the reinforcement intervention.
Interventions
- OTHER Standard of care
- BEHAVIORAL Reinforcement for BG testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2014-07 |
| Est. Completion | 2019-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02167243
The ClinicalTrials.gov registry entry for NCT02167243 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of care is the first listed.
NCT02167243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02167243 about?
NCT02167243 is a clinical study titled "A Reinforcement Approach to Improve Diabetes Management". The purpose of this project is to evaluate the efficacy of a behavioral economic intervention to improve self monitoring of blood glucose (SMBG) in adolescents and young adults with T1D. The intervention will reinforce patients for conducting SMBG, with escalating reinforcers provided when patients ...
What is the current status of trial NCT02167243?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2014-07. Estimated completion is 2019-11.
What interventions are being tested in trial NCT02167243?
The interventions under investigation include: Standard of care (OTHER), Reinforcement for BG testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02167243?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.